Preferential histiotypic expression of CD44-isoforms in human lung cancer

Lung Cancer

Volumn 16, Issue 2-3, 1997, Pages 151-172

  Wimmel, Anja ^a   Schilli, Margret ^a   Kaiser, Ulrich ^a   Havemann, Klaus ^a   Ramaswamy, Anette ^a   Branscheid, Detlev ^b   Kogan, Eugenia ^c   Schuermann, Marcus ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Zentrum fur Pneumonologie und T   (Germany)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

adhesion molecule; CD44; differentiation marker; immunohistochemistry; lung cancer

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN;

ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; ALTERNATIVE SPLICING; ANTIGENS, CD; ANTIGENS, CD44; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE; DNA PRIMERS; EXONS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030925367     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(96)00625-3     Document Type: Article

References (43)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-1313.
2. Haynes B, Liao HX, Patton K. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991; 3: 347-350.
3. Herrlich P, Zöller M, Pals ST, Ponta H. CD44 splice variants: metastases meet lymphocytes. Immunol Today 1993; 14: 395-399.
4. Günthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993; 194: 47-63.
5. Lesley J, Hyman R, Kincade PW. CD44 and its interactions with the extracellular matrix. Adv Immunol 1993; 54: 271-335.
6. Ruiz P, Schwärzler C, Günthert U. CD44 isoforms during differentiation and development. BioEssays 1995; 17: 17-24.
7. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992; 267: 4732-4739.
8. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-12164.
9. Brown TA, Bouchard T, St John T, Wayner E, Carter WG. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 1991; 113: 207-221.
10. Shtivelman E, Bishop M. Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 1991; 11: 5446-5453.
11. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 1994; 54: 4238-4242.
12. Fujita N, Yaegashi N, Ide Y, Sato S, Nakamura M, Ishiwata I, Yajima A. Expression of CD44 in normal human versus Tumour endometral tissue: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 1994; 54: 3922-3928.
13. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumours of squamocellular origin. J Cell Biol 1993; 122: 431-442.
14. Asplund T, Heldin P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res 1994; 54: 4516-4523.
15. Heider K-H, Hofmann M, Horst E, van den Berg F, Ponta H, Herrlich P, Pals STA. The human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and in adenomatous polyps. J Cell Biol 1993; 120: 227-233.
16. Tanabe KT, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993; 341: 725-726.
17. Wielenga VJ M, Heider K-H, Offerhaus JA., Adolf GR, Berg, vdFM, Ponta H, Herrlich, P, Pals, ST. Expression of CD44 variant proteins in human colorectal cancer is related to tumour progression. Cancer Res 1993; 53: 4754-4756.
18. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
19. Mayer B, Jauch KW, Günthert B, Figdor CG, Schildberg FW, Funke I, Johnson JP. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993; 342: 1019-1022.
20. Heider K-H, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H. Different expression of CD44 splice variants in intestinal and diffuse type human gastric carcinoma and normal gastric mucosa. Cancer Res 1993; 53: 4197-4203.
21. Kaufmann M, Heider K-H, Sinn H-P, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-619.
22. Stauder R, Eisterer W, Thaler J, Günthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995; 85: 2885-2899.
23. Gansauge F, Gansauge S, Zobywalski A, Scharnweber C, Link KH, Nussler AK, Beger HG. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer Res 1995; 55: 5499-5503.
24. Dall P, Heider K-H, Hekele A. Surface protein expression and mRNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994; 54: 3337-3341.
25. Penno MB, August JT, Baylin SB, Mabry M, Linnoila I, Lee VS, Croteax D, Yangz XL, Rosada C. Expression of CD44 in human lung tumours. Cancer Res 1994; 54: 1381-1387.
26. Ariza A, Mate JL, Isamat M, López D, Von Uexküll-Güldebrand C, Rosell R, Fernández-Vasalo A, Navas-Palacios J. Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but not of the small cell type. J Pathol 1995; 177: 363-368.
27. Jackson DG, Schenker T, Waibel R, Bell, JI, Stahel RA. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer 1994; 8: 110-115.
28. Washimi O, Ueda R, Ariyoshi Y, Suyama S, Seki T, Takahashi T, Takahashi T. Expression of CD44 variant isoforms in normal and neoplastic cells of the lung. Jpn J Cancer Res 1994; 85: 1112-1116.
29. Carney DM, Gazdar, AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 1985; 45: 2913-2923.
30. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie H, Linnoila RI, Mulshine JL, Minna JD, Gazdar AF. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992; 7: 171-180.
31. Pettengill OS, Sorenson GD, Wurster-Hill DH, Curphey TJ, Noll WW, Cate CC, Maurer LH. Isolation and characteristics of continous cell lines from small cell carcinoma of the lung. Cancer 1980; 45: 906-918.
32. Bergh J, Nilsson K, Ekman R, Giovanella, B. Establishment and characterisation of cell lines from human small cell and large cell carcinomas of the lung. APMIS 1985; 93: 133-147.
33. Bepler G, Jacques G, Koehler A, Gropp C, Havemann K. Markers and characteristics of human SCLC cell lines. J Cancer Res Clin Oncol 1987; 113: 253-259.
34. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current protocols in molecular biology. Chichester: Wiley Interscience, 1987.
35. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 1984; 133: 1710-1715.
36. Koopman G, Heider K-H, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.
37. Picardo AL, Torres AJ, Maestro M, Ortega D, Garcia-Asenjo JA, Muguerza JM, Hernando F, Diez M, Balibrea JL. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer. Cancer 1994; 73: 2305-2311.
38. Tesfaigzi J, Wright PS, Oreffo V, An G, Wu R, Carlson DM. A small proline-rich protein regulated by vitamin A in tracheal epithelial cells is induced in lung tumors. Am J Respir Cell Mol Biol 9: 434-440.
39. Givehchian M, Woerner SM, Lacroix J, Zoller M, Drings P, Becker H, Kayser K, Ridder R, von-Knebel-Doeberitz M. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. Oncogene 1996; 12: 1137-1144.
40. Teder P, Bergh J, Heldin P. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines. Cancer Res 1995; 55: 3908-3914.
41. Mackay CR, Terpe HJ., Stauder R, Marston Wl, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994; 124: 71-82.
42. Gazdar AF, Linnoila RI. The pathology of lung cancer: changing concepts and newer diagnostic techniques. Semin Oncol 1988; 15: 215-225.
43. Hammar SP. Common neoplasms. In: Dail DH, Hammar SP, editors. Pulmonary pathology. New York: Springer Verlag, 1987: 727-845.